We are live on ! Find out more
CCM

Coldstream Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 17.95%
This Fund
S&P 500
This Quarter Est. Return
-1.83%
1 Year Est. Return
+17.95%
3 Year Est. Return
+59.03%
5 Year Est. Return
10 Year Est. Return
AUM
$4.7B
AUM Growth
+$4.46M
Cap. Flow
+$147M
Cap. Flow %
3.12%
Top 10 Hldgs %
39.64%
Holding
3,543
New
2,477
Increased
543
Reduced
471
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 12.69%
2 Financials 5.41%
3 Consumer Discretionary 4.72%
4 Healthcare 4.05%
5 Industrials 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBT icon
3051
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.75B
$1.7K ﹤0.01%
+10
New +$1.74K
RLGT icon
3052
Radiant Logistics
RLGT
$391M
$1.7K ﹤0.01%
+276
New +$1.87K
ADT icon
3053
ADT
ADT
$5.57B
$1.69K ﹤0.01%
+208
New +$1.57K
FRBA icon
3054
First Bank
FRBA
$468M
$1.69K ﹤0.01%
+114
New +$1.68K
NOVA
3055
DELISTED
Sunnova Energy
NOVA
$1.69K ﹤0.01%
+4,540
New +$8.74K
ITIC
3056
Investors Title Co
ITIC
$544M
$1.69K ﹤0.01%
+7
New +$1.62K
KODK icon
3057
Kodak
KODK
$949M
$1.69K ﹤0.01%
+267
New +$1.85K
CGNG
3058
Capital Group New Geography Equity ETF
CGNG
$2.8B
$1.69K ﹤0.01%
+67
New +$1.71K
CMPX icon
3059
Compass Therapeutics
CMPX
$340M
$1.67K ﹤0.01%
+879
New +$2.34K
KLRS
3060
Kalaris Therapeutics
KLRS
$98M
$1.67K ﹤0.01%
+208
New +$2.04K
OPAL icon
3061
OPAL Fuels
OPAL
$71.3M
$1.67K ﹤0.01%
+905
New +$2.48K
GLUE icon
3062
Monte Rosa Therapeutics
GLUE
$1.31B
$1.65K ﹤0.01%
+355
New +$2.18K
BHC icon
3063
Bausch Health
BHC
$2.33B
$1.63K ﹤0.01%
+252
New +$1.81K
DAWN
3064
DELISTED
Day One Biopharmaceuticals
DAWN
$1.63K ﹤0.01%
+205
New +$2.21K
EVEX icon
3065
Eve Holding
EVEX
$923M
$1.62K ﹤0.01%
+488
New +$2.11K
WEAV icon
3066
Weave Communications
WEAV
$541M
$1.61K ﹤0.01%
+145
New +$2.08K
TTMI icon
3067
TTM Technologies
TTMI
$13.9B
$1.6K ﹤0.01%
+78
New +$1.89K
WGS icon
3068
GeneDx Holdings
WGS
$2.08B
$1.59K ﹤0.01%
+18
New +$1.56K
HLLY icon
3069
Holley
HLLY
$361M
$1.59K ﹤0.01%
+619
New +$1.74K
RYTM icon
3070
Rhythm Pharmaceuticals
RYTM
$7.49B
$1.59K ﹤0.01%
+30
New +$1.66K
NUW icon
3071
Nuveen AMT-Free Municipal Value Fund
NUW
$251M
$1.58K ﹤0.01%
+115
New +$1.59K
TIGO icon
3072
Millicom
TIGO
$15.5B
$1.57K ﹤0.01%
+52
New +$1.43K
HTZ icon
3073
Hertz
HTZ
$480M
$1.57K ﹤0.01%
+398
New +$1.6K
CGEM icon
3074
Cullinan Oncology
CGEM
$1.07B
$1.57K ﹤0.01%
+207
New +$1.99K
SD icon
3075
SandRidge Energy
SD
$494M
$1.56K ﹤0.01%
+137
New +$1.63K

Similar funds

Coldstream Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Coldstream Capital Management held 3,543 positions worth $4.7B, up 0.1% from $4.69B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Coldstream Capital Management deployed $147M of net new capital in Q1 2025, opening 2,477 new positions and adding to 543 existing holdings. Its largest new stake was iShares 3-7 Year Treasury Bond ETF: 71,368 shares worth $8.43M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $139M trimmed.

  • Coldstream Capital Management's largest Q1 2025 buy was iShares 3-7 Year Treasury Bond ETF: 71,368 shares worth $8.43M.
  • Coldstream Capital Management added most to iShares Russell 1000 ETF in Q1 2025, an estimated $48.2M increase.
  • Coldstream Capital Management's biggest Q1 2025 reduction was Microsoft, cutting an estimated $139M.
  • Coldstream Capital Management fully exited Innovator US Equity Power Buffer ETF June in Q1 2025, selling an estimated $345K.
  • Coldstream Capital Management's ten largest holdings make up 40% of its $4.7B portfolio in Q1 2025.
  • Coldstream Capital Management opened 2,477 new positions and closed 3 in Q1 2025.
  • Coldstream Capital Management's portfolio value rose 0.1% quarter-over-quarter to $4.7B.

Based on Coldstream Capital Management's 13F filing for Q1 2025, filed 13 May 2025.